Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
Go back to Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies| CACI INTERNATIONAL CLA (NASDAQ: CAI) | Delayed: 17.47 +0.16 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.31 | 52 Week High | $11.53 | |||
| Open | $17.59 | 52 Week Low | $4.83 | |||
| Day High | $17.59 | P/E | 5.92 | |||
| Day Low | $16.82 | EPS | $2.95 | |||
| Volume | 242,959 | |||||
